All In MedTech

FDA Clearance Tracker · P100034-S008

NOVO TTF-100A SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 24, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 24, 2014

Approved

Time to decision

181 days

Received Jan 24, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P100034-S008
Device name
NOVO TTF-100A SYSTEM
Applicant location
Baar
Received
Jan 24, 2014
Decided
Jul 24, 2014
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P100034

Device type

Device class
Class III

Every decision under product code NZK

FDA's approval statement

As written in FDA's record.

APPROVAL TO REPLACE THE CURRENT TYVEK POUCH PACKAGING MATERIAL FOR THE INE TRANSDUCER ARRAYS WITH AN ALUMINUM FOIL MOISTURE BARRIER AND TO EXTEND THE SHELF LIFE FOR THESE TRANSDUCER ARRAYS FROM 6 TO 9 MONTHS.

Source documents

Other decisions for Novocure, GmbH

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.